Answers are grounded in this paper and cite their sources.
Medicines dominate out-of-pocket health spending in Central America, particularly for households requiring chronic treatment. Using 8746 households from Honduras’s 2023–2024 National Household Income and Expenditure Survey and design-based methods, we assessed catastrophic spending on medicines (10% and 25% of consumption; 40% of capacity to pay), impoverishment and socioeconomic inequality, using concentration indices, decompositions and two-part models of the expenditure share. Medicines accounted for 54.8% of out-of-pocket health spending. Overall, 8.2% (95% CI: 7.1–9.3%) of the population incurred catastrophic spending at 10%: 23.4% in households using chronic-disease medicines versus 3.0% in other households, a gap that is partly mechanical. With households ranked by total consumption, catastrophic spending appeared concentrated among better-off households (Erreygers index 0.035), but this gradient disappeared when ranking by consumption net of health spending (−0.019), under which catastrophic spending at higher thresholds and impoverishment (1.6% of the population) were concentrated among the poor. Use of chronic-disease medicines was pro-rich under both rankings, and socioeconomic differences operated through whether households paid at all rather than through the share paid. Unmet need is one plausible explanation, alongside differences in diagnosis and prevalence.
No takes yet. Share an insight, caveat, or question.
Ramírez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: